AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mishkin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mishkin, S.
Agricola
Right arrow Articles by Mishkin, S.

American Journal of Clinical Nutrition, Vol 65, 564-567, Copyright © 1997 by The American Society for Clinical Nutrition, Inc

REVIEW ARTICLES

Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease

S Mishkin
Department of Medicine, McGill University, Montreal, Quebec, Canada. dmishk@po-box.mcgill.ca

The ability of inflammatory bowel disease (IBD) patients to tolerate dairy products and the guidance they receive from physicians and nutritionists on this subject are important considerations in the management of their IBD. Although most affected persons are able to consume a glass of milk daily without discomfort, additional consideration must be given to specific factors that can be relevant to certain individuals. The declaration by patients that they are "dairy sensitive" may be related to lactose intolerance or malabsorption, the long-chain triacylglycerol content of milk, allergy to milk proteins, as well as psychologic factors and the misconception that dairy products can be detrimental to their health. The prevalence of lactose malabsorption is significantly greater in patients with Crohn disease involving the small bowel than it is in patients with Crohn disease involving the colon or ulcerative colitis. In the latter colonic conditions the prevalence of lactose malabsorption is mainly determined by ethnic risk, which is based on genetic factors. In addition, lactose malabsorption in Crohn disease of the small bowel may be determined by factors other than lactase enzyme activity, such as bacterial overgrowth and/or small bowel transit time. Physicians differ widely in the advice they give their patients: some dogmatically advise avoidance of dairy products when the diagnosis is made whereas others discount the possible role of dairy in the management of IBD. IBD patients avoid dairy products more than they would need to based on the prevalence of lactose malabsorption and/or milk intolerance, probably partly because of incorrect patient perceptions and arbitrary advice from physicians and authors of popular diet books. Adequate scientific and clinical information is now available to permit recommendations about the intake of dairy products for each IBD patient.


This article has been cited by other articles:


Home page
 PediatricsHome page
M. B. Heyman and for the Committee on Nutrition
Lactose Intolerance in Infants, Children, and Adolescents
Pediatrics, September 1, 2006; 118(3): 1279 - 1286.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S Collins and M Verma-Gandhu
The putative role of endogenous and exogenous opiates in inflammatory bowel disease.
Gut, June 1, 2006; 55(6): 756 - 757.
[Full Text] [PDF]

Home page
 GutHome page
C Gasche, M C E Lomer, I Cavill, and G Weiss
Iron, anaemia, and inflammatory bowel diseases
Gut, August 1, 2004; 53(8): 1190 - 1197.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by The American Society for Nutrition